Serum Institute seeks nod to export 32.4 lakh doses of its COVID vaccine Covovax to US
It will be the first vaccine to be exported to the country by any Indian manufacturer, according to official sources
The Serum Institute has sought the Centre’s approval to export 32.4 lakh doses of the COVID-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported to the country by any Indian manufacturer, official sources said last week.
According to a communication sent to the government by Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, the shipment is likely to be dispatched on 3rd July if due approval come in time, an official source told PTI. The sources said it will be the first instance of any Indian manufacturer’s vaccine — COVID or non-COVID — to be exported to the US.
“It is a matter of pride for us and our country that in line with clarion call of our Prime Minister Narendra Modi ji’s ‘Making in India for the world’ and under leadership of our CEO, Dr Adar C Poonawalla, our made in India world class Covovax vaccine will be the first life-saving vaccine of our country to be exported to United States of America. Also, our firm is committed to fulfill the dream of our PM to make India a pharmacy hub of the world,” Singh has said in his communication, according to an official source.
Edits by EP News Bureau